Detalles de la búsqueda
1.
Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19.
N Engl J Med
; 385(15): 1382-1392, 2021 10 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34260849
2.
A Randomized, Placebo-Controlled Clinical Trial of Bamlanivimab and Etesevimab Together in High-Risk Ambulatory Patients With COVID-19 and Validation of the Prognostic Value of Persistently High Viral Load.
Clin Infect Dis
; 75(1): e440-e449, 2022 08 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-34718468
3.
Effect of Bamlanivimab vs Placebo on Incidence of COVID-19 Among Residents and Staff of Skilled Nursing and Assisted Living Facilities: A Randomized Clinical Trial.
JAMA
; 326(1): 46-55, 2021 07 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34081073
4.
Financing and Distribution of Pharmaceuticals in the United States.
JAMA
; 318(1): 21-22, 2017 Jul 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28505252
5.
Risk Factors Associated with COVID-19 Hospitalization and Mortality: A Large Claims-Based Analysis Among People with Type 2 Diabetes Mellitus in the United States.
Diabetes Ther
; 12(8): 2223-2239, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-34275115
Resultados
1 -
5
de 5
1
Próxima >
>>